Apr. 22 at 4:41 PM
$DERM There is a gap to be filled at
$6.65. What brings it back up to close the gap is a turnaround in realized pricing per script.
$180 just sucked the air out of the room for the investor.
We hit
$9.40-ISH on the runup last earnings due to anticipated increase in revenue per script. Obviously, it went the wrong way. Er go the precipitous drop. A return to the
$200's/script will only close the gap IMO. To get it back to the
$9's, we need to see back to back increases in realized pricing, and high
$300's. Realistically, there is a path by Q2/CC. Also, getting that 3rd major HCP is foundationally highly Bullish!
I bought another grip of shares at
$4.99 this morning. The overall chart is screaming its a smoking buy. Closing the gap is a solid 30%+ increase from here.
Nothing wrong with the company or product. Its simply the path to realized pricing increasing over the next 18-24 months. I still see north of
$20 in 24 months.
Very Bullish.
